We are live on
!
Find out more
Two Sigma Advisers Portfolio holdings
AUM
$51.4B
1-Year Est. Return
31.07%
This Fund
S&P 500
This Quarter
Est. Return
-3.02%
1 Year Est. Return
+31.07%
3 Year Est. Return
+128.94%
5 Year Est. Return
+161.75%
10 Year Est. Return
+607.04%
AUM
$34.5B
AUM Growth
-$708M
(-2%)
Cap. Flow
+$1.23B
Cap. Flow
% of AUM
3.55%
Top 10 Holdings %
Top 10 Hldgs %
13.77%
Holding
2,852
New
233
Increased
919
Reduced
1,343
Closed
332
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Enphase Energy
ENPH
|
+$342M |
| 2 |
Intel
INTC
|
+$276M |
| 3 |
TSMC
TSM
|
+$237M |
| 4 |
Procter & Gamble
PG
|
+$178M |
| 5 |
JPMorgan Chase
JPM
|
+$170M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$383M |
| 2 |
Occidental Petroleum
OXY
|
+$321M |
| 3 |
PayPal
PYPL
|
+$316M |
| 4 |
S&P Global
SPGI
|
+$145M |
| 5 |
Datadog
DDOG
|
+$133M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.57% |
| 2 | Healthcare | 17.95% |
| 3 | Financials | 9.89% |
| 4 | Industrials | 9.61% |
| 5 | Consumer Discretionary | 7.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BLUE
2201
DELISTED
bluebird bio
BLUE
| $199K | ﹤0.01% |
1,570
-10,550
| -87% | -$1.19M |
|
2202
Cars.com
CARS
$705M
| $199K | ﹤0.01% |
17,267
-100,106
| -85% | -$1.18M |
|
2203
Alto Ingredients
ALTO
$345M
| $198K | ﹤0.01% |
54,293
-34,000
| -39% | -$143K |
|
|
GBIO
2204
DELISTED
Generation Bio
GBIO
| $198K | ﹤0.01% |
3,720
+1,640
| +79% | +$103K |
|
|
SEEL
2205
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
| $198K | ﹤0.01% |
50
-105
| -68% | -$413K |
|
2206
BGSF Inc
BGSF
$56.6M
| $196K | ﹤0.01% |
17,600
-1,000
| -5% | -$12.4K |
|
|
BPT
2207
DELISTED
BP Prudhoe Bay Royalty Trust
BPT
| $196K | ﹤0.01% |
+16,400
| New | +$266K |
|
2208
EVI Industries
EVI
$194M
| $196K | ﹤0.01% |
10,800
-2,100
| -16% | -$24.8K |
|
2209
Companhia Siderúrgica Nacional
SID
$1.46B
| $195K | ﹤0.01% |
82,000
+39,800
| +94% | +$110K |
|
|
EIGR
2210
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $195K | ﹤0.01% |
862
+522
| +154% | +$128K |
|
|
UBA
2211
DELISTED
Urstadt Biddle Properties Inc. Class A
UBA
| $194K | ﹤0.01% |
12,500
-1,600
| -11% | -$27.2K |
|
|
ASRT
2212
DELISTED
Assertio
ASRT
| $193K | ﹤0.01% |
5,677
+1,097
| +24% | +$49.6K |
|
|
WE
2213
DELISTED
WeWork Inc.
WE
| $193K | ﹤0.01% |
1,818
+1,080
| +146% | +$194K |
|
2214
Cullinan Oncology
CGEM
$1.07B
| $192K | ﹤0.01% |
+15,000
| New | +$202K |
|
2215
Voyager Therapeutics
VYGR
$184M
| $191K | ﹤0.01% |
32,300
+1,600
| +5% | +$10.2K |
|
|
CMLS
2216
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
| $191K | ﹤0.01% |
27,100
-37,200
| -58% | -$316K |
|
2217
Porch Group
PRCH
$1.38B
| $190K | ﹤0.01% |
84,400
-30,500
| -27% | -$73.8K |
|
2218
ZipRecruiter
ZIP
$348M
| $190K | ﹤0.01% |
11,500
-3,400
| -23% | -$59.3K |
|
|
MTEM
2219
DELISTED
Molecular Templates, Inc.
MTEM
| $189K | ﹤0.01% |
16,769
-6,880
| -29% | -$86.5K |
|
|
TBNK
2220
DELISTED
Territorial Bancorp Inc.
TBNK
| $188K | ﹤0.01% |
10,114
-10,100
| -50% | -$213K |
|
2221
Veritone
VERI
$96.7M
| $187K | ﹤0.01% |
33,300
-4,400
| -12% | -$30.9K |
|
2222
Immatics
IMTX
$1.19B
| $186K | ﹤0.01% |
+18,600
| New | +$201K |
|
2223
DLH Holdings
DLHC
$75.7M
| $185K | ﹤0.01% |
+15,100
| New | +$238K |
|
2224
Intellicheck
IDN
$73.7M
| $185K | ﹤0.01% |
73,300
-37,600
| -34% | -$96.7K |
|
|
PW
2225
Power REIT
PW
$3.23M
| $185K | ﹤0.01% |
1,730
-300
| -15% | -$44.4K |
|
Similar funds
CWM
VRS
FAF
BGIM
CIM
PPFA
Two Sigma Advisers's Q3 2022 Portfolio in Review
As of Q3 2022, Two Sigma Advisers held 2,852 positions worth $34.5B, down 2% from $35.3B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Two Sigma Advisers deployed $1.23B of net new capital in Q3 2022, opening 233 new positions and adding to 919 existing holdings. Its largest new stake was State Street SPDR S&P Biotech ETF: 1,329,800 shares worth $105M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Netflix, an estimated $383M trimmed.
- Two Sigma Advisers's largest Q3 2022 buy was State Street SPDR S&P Biotech ETF: 1,329,800 shares worth $105M.
- Two Sigma Advisers added most to Enphase Energy in Q3 2022, an estimated $342M increase.
- Two Sigma Advisers's biggest Q3 2022 reduction was Netflix, cutting an estimated $383M.
- Two Sigma Advisers fully exited S&P Global in Q3 2022, selling an estimated $145M.
- Two Sigma Advisers's ten largest holdings make up 14% of its $34.5B portfolio in Q3 2022.
- Two Sigma Advisers opened 233 new positions and closed 332 in Q3 2022.
- Two Sigma Advisers's portfolio value fell 2% quarter-over-quarter to $34.5B.
Based on Two Sigma Advisers's 13F filing for Q3 2022, filed 14 Nov 2022.